Journal of genetics and genomics = Yi chuan xue bao
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a basic science related to Inflammatory bowel disease, Microbiome, and Research and clinical trials. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of genetics and genomics = Yi chuan xue bao
AuthorsXiangyong Wei, Guozhen Wu, Da Zhang +7 more
InstitutionInstitute of Developmental Biology and Regenerative Medicine, Southwest University, Chongqing 400715, China.
Study typeLetter
Indexed viaPubMed
Source typeResearch paper
PublishedOct 9, 2026, 12:00 AM
Content availableMetadata only
Conflict statement: Conflict of interest The authors declare no competing interests.
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Tegoprazan regulates gut microbiota structure in Helicobacter pylori-induced ulcerative colitis mice
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Microbiome. The original article is from Folia Microbiologica.
Cinnamaldehyde-hollow mesoporous Prussian blue nanozymes for ulcerative colitis via reactive oxygen and nitrogen species scavenging and gut microbiota-metabolism modulation
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Microbiome. The original article is from Journal of Drug Delivery Science and...
Engineered microvesicle-mediated multimodal therapy resolves ulcerative colitis via synergistic immunoregulation, barrier restoration, and microbiota remodeling
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Microbiome. The original article is from Materials today. Bio.